Reuters logo
BRIEF-MiMedx files with FDA to initiate Investigational New Drug Achilles Tendonitis Phase 3 clinical trial
August 4, 2017 / 9:28 PM / 2 months ago

BRIEF-MiMedx files with FDA to initiate Investigational New Drug Achilles Tendonitis Phase 3 clinical trial

Aug 4 (Reuters) - MiMedx Group Inc

* MiMedx files with the FDA to initiate its Investigational New Drug Achilles Tendonitis Phase 3 clinical trial

* MiMedx Group Inc - ‍company expects patient enrollment to commence in next few months​

* MiMedx Group Inc - ‍plans to submit a Biologic License Application (BLA) to FDA for Tendonitis when company’s Plantar Fasciitis Phase 3 trial completes​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below